15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
Public ClinicalTrials.gov record NCT01157351. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Fifteen-month, Prospective, Randomized, Active-controlled, Open-label, Flexible Dose Study of Paliperidone Palmitate Compared With Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults With Schizophrenia Who Have Been Incarcerated
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study will assess the use of paliperidone palmitate compared with oral antipsychotic treatment in delaying time to a protocol-defined treatment failure over 15 months, in patients diagnosed with schizophrenia who have been incarcerated.
Study identification
- NCT ID
- NCT01157351
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 450 participants
Conditions and interventions
Conditions
Interventions
- paliperidone Drug
- risperidone Drug
- haloperidole Drug
- perphenazine Drug
- aripiprazole Drug
- quetiapine Drug
- paliperidone palmitate Drug
- olanzapine Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2010 (Type not available)
- Primary completion
- Dec 2013 (Actual)
- Completion
- Dec 2013 (Actual)
- Last update posted
- Apr 24, 2015
2010 – 2013
United States locations
- U.S. sites
- 55
- U.S. states
- 22
- U.S. cities
- 55
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Bullhead City | Arizona | — | — |
| Not listed | Tuscon | Arizona | — | — |
| Not listed | Little Rock | Arkansas | — | — |
| Not listed | Anaheim | California | — | — |
| Not listed | Escondido | California | — | — |
| Not listed | Glendale | California | — | — |
| Not listed | Imperial | California | — | — |
| Not listed | Long Beach | California | — | — |
| Not listed | National City | California | — | — |
| Not listed | Oakland | California | — | — |
| Not listed | Oceanside | California | — | — |
| Not listed | Pico Rivera | California | — | — |
| Not listed | Riverside | California | — | — |
| Not listed | San Bernadino | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | San Fran Cisco | California | — | — |
| Not listed | New Britain | Connecticut | — | — |
| Not listed | New London | Connecticut | — | — |
| Not listed | Leesburg | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Miami Gardens | Florida | — | — |
| Not listed | Pensacola | Florida | — | — |
| Not listed | Tamarac | Florida | — | — |
| Not listed | Tampa | Florida | — | — |
| Not listed | Honolulu | Hawaii | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | Hoffman Estates | Illinois | — | — |
| Not listed | Naperville | Illinois | — | — |
| Not listed | Springfield | Illinois | — | — |
| Not listed | Wichita | Kansas | — | — |
| Not listed | Witchita | Kansas | — | — |
| Not listed | New Orleans | Louisiana | — | — |
| Not listed | Shreveport | Louisiana | — | — |
| Not listed | Flowood | Mississippi | — | — |
| Not listed | Kansas City | Missouri | — | — |
| Not listed | Omaha | Nebraska | — | — |
| Not listed | Las Vegas | Nevada | — | — |
| Not listed | Paramus | New Jersey | — | — |
| Not listed | Willingboro | New Jersey | — | — |
| Not listed | Buffalo | New York | — | — |
| Not listed | New York | New York | — | — |
| Not listed | Cleveland | Ohio | — | — |
| Not listed | Middleburg Heights | Ohio | — | — |
| Not listed | Willoughby | Ohio | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Allentown | Pennsylvania | — | — |
| Not listed | Philadelphia | Pennsylvania | — | — |
| Not listed | Charleston | South Carolina | — | — |
| Not listed | Nashville | Tennessee | — | — |
| Not listed | DeSoto | Texas | — | — |
| Not listed | Irving | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Wharton | Texas | — | — |
| Not listed | Bothell | Washington | — | — |
| Not listed | Spokane | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01157351, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 24, 2015 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01157351 live on ClinicalTrials.gov.